Seasonal effectiveness of live attenuated and inactivated influenza vaccine

Pediatrics

Volumn 137, Issue 2, 2016, Pages

  Chung, Jessie R ^a,b   Flannery, Brendan ^b   Thompson, Mark G ^b   Gaglani, Manjusha ^c   Jackson, Michael L ^d   Monto, Arnold S ^e   Nowalk, Mary Patricia ^f   Talbot, H Keipp ^g   Treanor, John J ^h   Belongia, Edward A ⁱ   Murthy, Kempapura ^c   Jackson, Lisa A ^d   Petrie, Joshua G ^e   Zimmerman, Richard K ^f   Griffin, Marie R ^g   McLean, Huong Q ⁱ   Fry, Alicia M ^b  

^a ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE; LIVE VACCINE;

ADOLESCENT; ARTICLE; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H1N1)PDM09; INFLUENZA A (H3N2); INFLUENZA B; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEASONAL VARIATION; CLINICAL TRIAL; COMPARATIVE STUDY; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; MULTICENTER STUDY; SEASON; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; SEASONS; UNITED STATES; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 84958720003     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-3279     Document Type: Article

References (37)

1. Fiore AE, Shay DK, Broder K, et al; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1-60
2. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: The pediatric experience. Pediatr Infect Dis J. 2001;20(8):733-740
3. Belshe RB, Edwards KM, Vesikari T, et al; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685-696
4. Fleming DM, Crovari P, Wahn U, et al; CAIV-T Asthma Study Group. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006;25(10):860-869
5. Ashkenazi S, Vertruyen A, Arístegui J, et al; CAIV-T Study Group. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006;25(10):870-879
6. Grohskopf LA, Olsen SJ, Sokolow LZ, et al; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014;63(32):691-697
7. Belongia EA, Kieke BA, Donahue JG, et al; Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199(2):159-167
8. Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011;29(38):6558-6563
9. Griffin MR, Monto AS, Belongia EA, et al; US Flu-VE Network. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 US communities. PLoS One. 2011;6(8):e23085
10. Treanor JJ, Talbot HK, Ohmit SE, et al; US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951-959
11. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319-327
12. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015;211(10):1529-1540
13. Gaglani M., Pruszynski J., Murthy K., et al. Influenza vaccine effectiveness against the 2009 pandemic A (H1N1) virus differed by vaccine-type during 2013-14 in the United States. Journal of Infectious Diseases. (In press)
14. Flannery B, Thaker SN, Clippard J, et al; Centers for Disease Control and Prevention (CDC). Interim estimates of 2013-14 seasonal influenza vaccine effectiveness: United States, February 2014. MMWR Morb Mortal Wkly Rep. 2014;63(7):137-142
15. Fiore AE, Uyeki TM, Broder K, et al; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1-62
16. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(33):1128-1132
17. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2012;61(32): 613-618
18. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep. 2013;62(RR-07 RR-7):1-43
19. Jackson ML, Nelson JC. The testnegative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31(17):2165-2168
20. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(30):3104-3109
21. Sullivan SG, Feng S, Cowling BJ. Potential of the test-negative design for measuring influenza vaccine effectiveness: A systematic review. Expert Rev Vaccines. 2014;13(12):1571-1591
22. Gordon M, Lumley T. forestplot: advanced forest plot using "grid" graphics. 1.0 ed. 2014
23. R Core Team. R: A Language and Environment for Statistical Computing. 3.1.1 ed. Vienna, Austria: R Foundation for Statistical Computing; 2014
24. Ambrose CS, Wu X, Knuf M, Wutzler P. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies. Vaccine. 2012;30(5):886-892
25. Uzicanin A, Thompson M, Smith P, et al; Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in Maine. J Infect Dis. 2012;206(7):1059-1068
26. Hadler JL, Baker TN, Papadouka V, et al. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years. J Infect Dis. 2012;206(1):49-55
27. Pannaraj PS, Wang H-L, Rivas H, et al. School-located influenza vaccination decreases laboratoryconfirmed influenza and improves school attendance. Clin Infect Dis. 2014;59(3):325-332
28. Myers CA, Faix DJ, Blair PJ. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Clin Infect Dis. 2011;53(2):207-208
29. Kwong J, Pereira J, Quach S, et al. Randomized Evaluation of Live Attenuated vs. Trivalent Inactivated Influenza Vaccines in Schools (RELATIVES) Pilot Study: Preliminary Results From the Household Surveillance Sub-Study. 2014. Available at: http://cic-cci. ca/sites/default/files/CIC2014-AbstractsProgram. pdf. Accessed July 22, 2015
30. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) Reaffirms Recommendation for Annual Influenza Vaccination. 2015. Available at: www.cdc.gov/media/releases/2015/s0226-acip. html. Accessed April 7, 2015
31. Cotter CR, Jin H, Chen Z. A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS Pathog. 2014;10(1):e1003831
32. Yang H, Chang JC, Guo Z, et al. Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins. J Virol. 2014;88(9):4828-4838
33. Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol. 2008;15(7):1042-1053
34. Coelingh K. Update on live attenuated influenza vaccine (LAIV) [PowerPoint presentation]. February 25, 2015 ACIP meeting
35. MedImmune LLC. A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children. 2011. Available at: https://clinicaltrials.gov/ct2/show/results/NCT01091246? sect= X5. Accessed April 8, 2015
36. Ilyushina NA, Haynes BC, Hoen AG, et al. Live attenuated and inactivated influenza vaccines in children. J Infect Dis. 2015;211(3):352-360
37. Mohn KG-I, Bredholt G, Brokstad KA, et al. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. J Infect Dis. 2015;211(10):1541-1549